Ventas, Inc.

VTR Real Estate REIT - Healthcare Facilities NYSE

PDF Back to Search

$80.61

+$0.16 (+0.20%)

Open: $80.39 | High: $80.87 | Low: $79.49 | Prev Close: $80.45

Market Cap: $35.66B

Volume: 1.6M | Avg: 2.9M

Last updated: December 05, 2025 at 10:07 PM
Investment Rating
C+

Sell

Overall Score: 40/100

Rating Breakdown:
DCF Score 3/5
60%
Neutral
ROE Score 2/5
40%
Sell
ROA Score 3/5
60%
Neutral
D/E Score 2/5
40%
Sell
P/E Score 1/5
20%
Strong Sell
P/B Score 2/5
40%
Sell
Add to Watchlist Add to Portfolio
Stock Score Analysis
E

Stock Score: 380

Comprehensive Quality Assessment

Component Breakdown:
Efficiency 5
Financial Health 40
Growth 20
Market Sentiment 0
Risk 5
Lower is better
Valuation 10
Momentum 0
View Full Stock Score Dashboard
Valuation Metrics
Valuation Ratios
P/E Ratio 152.09
P/B Ratio 2.93
P/S Ratio 6.42
EPS $0.53
Beta 0.79
Shares Outstanding 442.43M
Price Range & Moving Averages
52-Week High $81.26
52-Week Low $56.68
SMA 50 $73.62
SMA 200 $68.28
Dividend Information
Dividend Yield 2.34%
Annual Dividend $1.89
Earnings
Next Earnings February 11, 2026 05:00 AM ET
Financial Ratios
Margins
Gross Margin 15.5%
Operating Margin 9.1%
Net Margin 1.0%
Returns
ROE 0.5%
ROA 0.2%
Liquidity & Leverage
Debt/Equity 1.04
Current Ratio 1.61
Quick Ratio 1.61
Balance Sheet
Total Assets $26.19B
Total Liabilities $15.36B
Total Equity $10.77B
Cash $897.85M
Total Debt $13.74B
Net Debt $12.84B
Income Statement
Revenue $4.92B
Gross Profit $2.10B
Operating Income $681.23M
Net Income $81.15M
EBITDA $1.94B
Revenue/Share $12.36
Cash Flow
Operating CF $1.33B
CapEx $603.85M
Free Cash Flow $725.78M
Book Value/Share $28.41
Tangible Book/Share $22.39
Equity/Share $27.50
Technical Indicators
RSI (14) 73.36 Overbought
MACD
1.99 Signal: 2.15
Volatility 21.24%
Trading Signal Overbought
Performance & Returns
Total Returns
1 Year +20.73%
Risk-Adjusted Returns
Sharpe Ratio 1.02 Good
Volatility (Ann.) 20.36% Moderate
vs S&P 500 (SPY)
VTR (1Y) +20.73%
S&P 500 (1Y) +11.86%
Alpha (Excess Return) +8.87%
Risk-free rate: 4.5% (3-month US Treasury) • Based on 199 trading days
Sector Comparison (Real Estate)
Compared to 30 peers in Real Estate
Metric VTR Sector Avg Percentile
P/E Ratio 152.09 61.24 90%
P/B Ratio 2.93 1.71 71%
ROE (%) 0.49% 24.33% 19%
Net Margin (%) 1.02% 17.42% 16%
Stock Score 380 472.0 10%
1Y Return (%) +20.73% -8.47% 97%
Percentile: 0% = worst in sector, 100% = best in sector
Historical Price Analysis (Last 200 Days)
Technical Analysis
Ticker Close SMA 5 SMA 8 SMA 13 SMA 50 SMA 200 RSI (14) MACD Volatility (%) Volume Signal SMA Decision
VTR $80.61 $80.31 $79.98 $79.83 $73.60 $68.27 73.36 1.99 21.24% 3339047 Strong Long Bullish Stack
Candlestick Patterns

There wasn't any recognizable pattern for the VTR stock

News Sentiment
📊 Ticker 📰 Headline 💭 Sentiment 📡 Source 🔗 URL
VTR Seniors Housing REITs: Generational Compounding Opportunity Neutral seekingalpha.com Read More
VTR Ventas Announces Pricing of Senior Notes Offering Neutral businesswire.com Read More
VTR Ventas (NYSE:VTR) Reaches New 1-Year High – Time to Buy? Neutral defenseworld.net Read More
VTR Reviewing Ventas (NYSE:VTR) and CareTrust REIT (NYSE:CTRE) Neutral defenseworld.net Read More
VTR Why Is Ventas (VTR) Up 7.7% Since Last Earnings Report? Neutral zacks.com Read More
Company Information

Ventas, an S&P 500 company, operates at the intersection of two powerful and dynamic industries: healthcare and real estate. As one of the world's foremost Real Estate Investment Trusts (REIT), we use the power of capital to unlock the value of real estate, partnering with leading care providers, developers, research and medical institutions, innovators and healthcare organizations whose success is buoyed by the demographic tailwind of an aging population. For more than twenty years, Ventas has followed a successful strategy that endures: combining a high-quality diversified portfolio of properties and capital sources to manage through cycles, working with industry leading partners, and a collaborative and experienced team focused on producing consistent growing cash flows and superior returns on a strong balance sheet, ultimately rewarding Ventas shareholders. As of September 30, 2020, Ventas owned or managed through unconsolidated joint ventures approximately 1,200 properties.

CEO Debra A. Cafaro
Employees 498
Country US
IPO Date 1997-05-05
Exchange NYSE
Website https://www.ventasreit.com
Sector Real Estate
Industry REIT - Healthcare Facilities
Similar Stocks (Real Estate - REIT - Healthcare Facilities)
WELL

Welltower Inc.

Price: $204.31
Change: +0.22%
Market Cap: $1402B
P/E: 140.90
Score: D (550)
View Details
DOC

Healthpeak Properties, Inc.

Price: $17.02
Change: -0.96%
Market Cap: $1182B
P/E: -283.67
Score: E (420)
View Details
Rating Metrics Explained
DCF Score (Discounted Cash Flow)

Measures the intrinsic value of the stock based on projected future cash flows. A higher score indicates the stock is undervalued relative to its DCF valuation.

ROE Score (Return on Equity)

Evaluates how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better profitability and management effectiveness.

ROA Score (Return on Assets)

Measures how efficiently a company uses its assets to generate profit. A higher ROA means better asset utilization and operational efficiency.

D/E Score (Debt-to-Equity)

Assesses the company's financial leverage and risk. Lower debt-to-equity ratios indicate less financial risk and better balance sheet health.

P/E Score (Price-to-Earnings)

Compares stock price to earnings per share. A lower P/E ratio may indicate the stock is undervalued, while a higher ratio could suggest overvaluation or growth expectations.

P/B Score (Price-to-Book)

Compares market price to book value per share. Lower P/B ratios may indicate undervaluation relative to the company's net asset value.

Rating Recommendations:

Each metric is scored on a scale of 1-5, where the scores are determined by comparing the company's performance against industry benchmarks and historical data:

  • Strong Buy (5/5): Excellent score - strong positive indicator
    • The metric significantly outperforms industry averages (top 20% of companies)
    • Indicates exceptional financial health or attractive valuation in that category
  • Buy (4/5): Good score - positive indicator
    • Above-average performance (top 40% of companies)
    • Shows strong fundamentals with room for improvement
  • Neutral (3/5): Average score - neutral indicator
    • Performance in line with industry median (middle 20%)
    • Neither significantly positive nor negative signal
  • Sell (2/5): Below average - negative indicator
    • Below-average performance (bottom 40% of companies)
    • Suggests weakness in this particular metric
  • Strong Sell (1/5): Poor score - strong negative indicator
    • Significantly underperforms industry (bottom 20%)
    • Indicates potential risk or overvaluation in that category
Note: The overall rating combines all six component scores to provide a comprehensive investment assessment. No single metric should be used in isolation for investment decisions.